OXFORD, England , June 1, 2022 /PRNewswire/ -- Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded a Biomedical catalyst grant by Innovate UK to progress a novel therapy for multiple myeloma patients. Multiple myeloma is an incurable...
Read More Details
Finally We wish PressBee provided you with enough information of ( Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients )
Also on site :